Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Sep 2, 2021
- Accession no.
- 0001209191-21-054604
- Filed
- Sep 2, 2021
- Trade date
- Aug 31-Sep 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.42M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2021 | Common Stock | SSaleDisposed | −19,520 | $30.12 | −$587,942.4 | 1,223,188 | Indirect | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −21,986 | $30.38 | −$667,934.68 | 1,201,202 | Indirect | |
| Sep 2, 2021 | Common Stock | SSaleDisposed | −5,400 | $30.15 | −$162,810 | 1,195,802 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.